Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[No title available]
[No authors listed] [No authors listed] PMID: 32345490
Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021.
Mazagatos C, Monge S, Olmedo C, Vega L, Gallego P, Martín-Merino E, Sierra MJ, Limia A, Larrauri A; Working Group for the surveillance and control of COVID-19 in Spain; Working group for the surveillance and control of COVID-19 in Spain. Mazagatos C, et al. Among authors: monge s. Euro Surveill. 2021 Jun;26(24):2100452. doi: 10.2807/1560-7917.ES.2021.26.24.2100452. Euro Surveill. 2021. PMID: 34142647 Free PMC article.
Phlebovirus-associated diseases transmitted by phlebotominae in Spain: Are we at risk?
García San Miguel L, Sierra MJ, Vazquez A, Fernandez-Martínez B, Molina R, Sanchez-Seco MP, Lucientes J, Figuerola J, de Ory F, Monge S, Suarez B, Simón F. García San Miguel L, et al. Among authors: monge s. Enferm Infecc Microbiol Clin (Engl Ed). 2021 Aug-Sep;39(7):345-351. doi: 10.1016/j.eimce.2021.05.001. Epub 2021 May 16. Enferm Infecc Microbiol Clin (Engl Ed). 2021. PMID: 34353512 Review.
Effectiveness of a Second Dose of an mRNA Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in Individuals Previously Infected by Other Variants.
Monge S, Rojas-Benedicto A, Olmedo C, Martín-Merino E, Mazagatos C, Limia A, Sierra MJ, Larrauri A, Hernán MA; IBERCovid. Monge S, et al. Clin Infect Dis. 2023 Feb 8;76(3):e367-e374. doi: 10.1093/cid/ciac429. Clin Infect Dis. 2023. PMID: 35687580 Free PMC article.
COVID-19 vaccine effectiveness against hospitalization due to SARS-CoV-2: A test-negative design study based on Severe Acute Respiratory Infection (SARI) sentinel surveillance in Spain.
Mazagatos C, Delgado-Sanz C, Monge S, Pozo F, Oliva J, Sandonis V, Gandarillas A, Quiñones-Rubio C, Ruiz-Sopeña C, Gallardo-García V, Basile L, Barranco-Boada MI, Hidalgo-Pardo O, Vazquez-Cancela O, García-Vázquez M, Fernández-Sierra A, Milagro-Beamonte A, Ordobás M, Martínez-Ochoa E, Fernández-Arribas S, Lorusso N, Martínez A, García-Fulgueiras A, Sastre-Palou B, Losada-Castillo I, Martínez-Cuenca S, Rodríguez-Del Águila M, Latorre M, Larrauri A; SARI surveillance VE group in Spain. Mazagatos C, et al. Among authors: monge s. Influenza Other Respir Viruses. 2022 Nov;16(6):1014-1025. doi: 10.1111/irv.13026. Epub 2022 Jul 26. Influenza Other Respir Viruses. 2022. PMID: 35880469 Free PMC article.
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022.
Sentís A, Kislaya I, Nicolay N, Meijerink H, Starrfelt J, Martínez-Baz I, Castilla J, Nielsen KF, Hansen CH, Emborg HD, Nardone A, Derrough T, Valenciano M, Nunes B, Monge S; VEBIS-Lot4 working group. Sentís A, et al. Among authors: monge s. Euro Surveill. 2022 Jul;27(30):2200551. doi: 10.2807/1560-7917.ES.2022.27.30.2200551. Euro Surveill. 2022. PMID: 35904059 Free PMC article.
Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study.
Fontán-Vela M, Hernando V, Olmedo C, Coma E, Martínez M, Moreno-Perez D, Lorusso N, Vázquez Torres M, Barbas Del Buey JF, Roig-Sena J, Pastor E, Galmés Truyols A, Artigues Serra F, Sancho Martínez RM, Latasa Zamalloa P, Pérez Martínez O, Vázquez Estepa A, García Rojas AJ, Barreno Estévez AI, Sánchez-Migallón Naranjo A, Pérez Martín JJ, Peces Jiménez P, Morales Romero R, Castilla J, García Cenoz M, Huerta Huerta M, Boone ALD, Macías Ortiz MJ, Álvarez Río V, Rodríguez Recio MJ, Merino Díaz M, Berradre Sáenz B, Villegas-Moreno MT, Limia A, Diaz A, Monge S; Spanish MPOX Vaccine Effectiveness Study Group. Fontán-Vela M, et al. Among authors: monge s. Clin Infect Dis. 2024 Feb 17;78(2):476-483. doi: 10.1093/cid/ciad645. Clin Infect Dis. 2024. PMID: 37864849 Free PMC article.
151 results